We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+7.84%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.42B
AUM Growth
+$116M
Cap. Flow
+$31.3M
Cap. Flow %
2.2%
Top 10 Hldgs %
38.27%
Holding
219
New
27
Increased
45
Reduced
60
Closed
9

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.69M
2
PYPL icon
PayPal
PYPL
+$5.46M
3
FMC icon
FMC
FMC
+$4.66M
4
PPLI
People Inc
PPLI
+$4.25M
5
AR icon
Antero Resources
AR
+$3.32M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$14.3M
2
AAPL icon
Apple
AAPL
+$5.37M
3
LBRDK icon
Liberty Broadband Class C
LBRDK
+$4.47M
4
CHTR icon
Charter Communications
CHTR
+$2.11M
5
PXD
Pioneer Natural Resource Co.
PXD
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 17.38%
2 Technology 17.25%
3 Materials 12.26%
4 Communication Services 9.41%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
126
Danaher
DHR
$138B
$1.25M 0.09%
5,020
– –
SCJ icon
127
iShares MSCI Japan Small-Cap ETF
SCJ
$255M
$1.12M 0.08%
15,000
– –
T icon
128
AT&T
T
$167B
$1.11M 0.08%
63,205
-17,280
-21% -$295K
HON icon
129
Honeywell
HON
$77.9B
$1.03M 0.07%
5,328
+3,183
+148% +$599K
BATRK icon
130
Atlanta Braves Holdings Series B
BATRK
$3.25B
$1M 0.07%
25,713
-730
-3% -$28.7K
NTR icon
131
Nutrien
NTR
$32.4B
$977K 0.07%
18,000
– –
WST icon
132
West Pharmaceutical
WST
$23.3B
$949K 0.07%
+2,400
New +$888K
ALC icon
133
Alcon
ALC
$32.8B
$948K 0.07%
+11,386
New +$913K
SONY icon
134
Sony
SONY
$131B
$943K 0.07%
55,000
– –
IWD icon
135
iShares Russell 1000 Value ETF
IWD
$81.5B
$904K 0.06%
5,050
– –
ISRG icon
136
Intuitive Surgical
ISRG
$128B
$895K 0.06%
+2,245
New +$848K
CRM icon
137
Salesforce
CRM
$142B
$894K 0.06%
2,971
– –
PEN icon
138
Penumbra
PEN
$12.6B
$892K 0.06%
+4,000
New +$989K
EOG icon
139
EOG Resources
EOG
$74.7B
$879K 0.06%
6,882
+2,382
+53% +$278K
ALNY icon
140
Alnylam Pharmaceuticals
ALNY
$37.2B
$859K 0.06%
+5,750
New +$959K
BAH icon
141
Booz Allen Hamilton
BAH
$8.59B
$859K 0.06%
5,790
+30
+0.5% +$4.22K
PFE icon
142
Pfizer
PFE
$141B
$851K 0.06%
30,698
-8,618
-22% -$239K
PRVA icon
143
Privia Health
PRVA
$3.11B
$822K 0.06%
+42,000
New +$887K
IVE icon
144
iShares S&P 500 Value ETF
IVE
$49.1B
$812K 0.06%
4,350
– –
LECO icon
145
Lincoln Electric
LECO
$14.1B
$802K 0.06%
+3,140
New +$742K
GPN icon
146
Global Payments
GPN
$23B
$778K 0.05%
5,824
-305
-5% -$40.3K
CET
147
Central Securities Corp
CET
$1.55B
$759K 0.05%
18,193
-1,395
-7% -$54K
IQV icon
148
IQVIA
IQV
$35.6B
$758K 0.05%
3,000
– –
MRVL icon
149
Marvell Technology
MRVL
$170B
$749K 0.05%
10,573
– –
VTI icon
150
Vanguard Total Stock Market ETF
VTI
$655B
$749K 0.05%
2,882
– –
4 5
6
7 8

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

S&CO Inc's Q1 2024 Portfolio in Review

As of Q1 2024, S&CO Inc held 219 positions worth $1.42B, up 8.9% from $1.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

S&CO Inc's Q1 2024 filing shows 27 new, 45 increased, 60 reduced and 9 closed positions. Its largest new stake was Illumina: 24,209 shares worth $3.23M. The largest sale was Bristol-Myers Squibb, an estimated $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Materials.

  • S&CO Inc's largest Q1 2024 buy was Illumina: 24,209 shares worth $3.23M.
  • S&CO Inc added most to UnitedHealth in Q1 2024, an estimated $9.69M increase.
  • S&CO Inc's biggest Q1 2024 reduction was Apple, cutting an estimated $5.37M.
  • S&CO Inc fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $14.3M.
  • S&CO Inc's ten largest holdings make up 38% of its $1.42B portfolio in Q1 2024.
  • S&CO Inc opened 27 new positions and closed 9 in Q1 2024.
  • S&CO Inc's portfolio value rose 8.9% quarter-over-quarter to $1.42B.

Based on S&CO Inc's 13F filing for Q1 2024, filed 9 May 2024.